Money Talk

Natco Pharma share price up over 4% on emergency approval for COVID-19 medicine

Natco Pharma share price up over 4% on emergency approval for COVID-19 medicine Baricitinib in combination with Remdesivir is used for the treatment of COVID-19 positive patients.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s